CFDE Workbench
Information Portal
Data Portal
Knowledge Portal
LOGIN
Search
Graph
Enrichment
Cross
Assistant
Data Matrix
Use Cases
Tools & Workflows
Submit
Documentation
processed
›
entity
›
kg assertion
›
1abc2388-ccf9-569d-b0b0-b3efe8ac9932
CFDE Workbench
JAK3 inhibitor II in similarity relationship with Erlotinib
(Knowledge Graph Assertion)
Target
:
Erlotinib
Compound (Entity type)
Source
:
JAK3 inhibitor II
Compound (Entity type)
Relation
:
in similarity relationship with
Knowledge Graph Relation (Entity type)
Dcc Asset
:
LINCS.zip
Processed File (Entity type)
Dcc
:
LINCS
DCC (Entity type)
Sab
:
LINCS
Evidence Class
:
0.5410912036895752
Results found
BACK TO SEARCH
CFDE Workbench
Report a bug
Consortium
About the CFDE
CF Programs
CFDE Centers
Partnerships
Pilot Projects
Community
Workbench Tutorial
Training & Outreach
Documentation
Get QR Codes
Funding Opportunities
Resources
Data & Metadata
Tools
Chatbot
Use Cases
Publications
@CFDE Workbench 2025
The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).
The DRC is funded by
OT2OD036435
from the
Common Fund at the National Institutes of Health
.
Consortium
About the CFDE
CF Programs
CFDE Centers
Partnerships
Pilot Projects
Community
Workbench Tutorial
Training & Outreach
Documentation
Get QR Codes
Funding Opportunities
Resources
Data & Metadata
Tools
Chatbot
Use Cases
Publications
CFDE Workbench
Report a bug
The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).
The DRC is funded by
OT2OD036435
from the
Common Fund at the National Institutes of Health
.
@CFDE Workbench 2025
This repository is under review for potential modification in compliance with Administration directives.